• Proceedings of the Optical Society of Korea Conference
• /
• 2000.08a
• /
• pp.36-37
• /
• 2000

정밀 지상관측 위성인 다목적실용위성 1호기에는 해상도 6.6 m인 전자광학카메라(EOC)가 탑재되어 현재 우수한 영상을 보내오고 있으며 2003년 발사예정인 2호기를 위하여 해상도 1 m의 Multispectral Camera(MSC)가 개발중이다. 미 TRW 사가 제작한 EOC 개발에 항우연의 연구진은 그 설계 및 시험의 각 단계별 검토와, 탑재, 위성전체 시험과 보정을 포함한 궤도운용 등의 수행과 함께, 개발기간 동안 현지에서 수행된 별도의 현장교육을 통하여 동급의 위성카메라를 실제 개발할 수 있는 설계기술을 이전받았다. 수차례 대구경 비구면 광학계 제작 경험을 더한 항우연은 MSC 공동개발선인 이스라엘 ELOP 사와 현재 그 설계를 진행하고 있다. (중략)

• Korean Journal of Remote Sensing
• /
• v.18 no.1
• /
• pp.13-23
• /
• 2002

A radiometric correction method is developed to apply multi-temporal KOMPSAT-1 EOC satellite images for the detection of land-cover changes b\ulcorner recognizing changes in reflection pattern. Radiometric correction was carried out to eliminate the atmospheric effects that could interfere with the image properly of the satellite data acquired at different multi-times. Four invariant features of water, sand, paved road, and roofs of building are selected and a linear regression relationship among the control set images is used as a correction scheme. It is found that the utilization of panchromatic multi-temporal imagery requires the radiometric scene standardization process to correct radiometric errors that include atmospheric effects and digital image processing errors. Land-cover with specific change pattern such as paddy field is extracted by seasonal change recognition process.

• Asian Pacific Journal of Cancer Prevention
• /
• v.16 no.16
• /
• pp.7237-7242
• /
• 2015

Background: Epithelial ovarian cancer (EOC) is the commonest malignancy involving the ovaries. Maximum surgical cytoreduction (MCR) followed by adjuvant taxane-platinum chemotherapy are the standard of care treatments. Aims: To study treatment outcomes of EOC patients that were maximally cyto-reduced and received adjuvant paclitaxel-carboplatin (PC) chemotherapy. Materials and Methods: This retrospective cohort study included 174 patients with EOC treated at the Egyptian National Cancer Institute between 2006 and 2010. For inclusion, they should have had undergone MCR with no-gross residual followed by adjuvant PC chemotherapy. MCR was total abdominal hysterectomy/bilateral salpingo-oophorectomy [TAH/BSO] or unilateral salpingo-oophorectomy [USO] plus comprehensive staging. Results: The median age was 50 years. Most patients were married (97.1%), had offspring (92.5%), were postmenopausal (53.4%), presented with abdominal/pelvic pain and swelling (93.7%), had tumors involving both ovaries (45.4%) without extra-ovarian extension i.e. stage I (55.2%) of serous histology (79.9%) and grade II (87.4%). TAH/BSO was performed in 97.7% of cases. A total of 1,014 PC chemotherapy cycles were administered and were generally tolerable with 93.7% completing 6 cycles. Alopecia and numbness were the commonest adverse events. The median follow up period was 42 months. The 2-year rates for disease free survival (DFS) and overall survival (OS) were 70.7% and 94.8%, respectively. The respective 5-year rates were 52.6% and 81.3%. Advanced stage and high-grade were significantly associated with poor DFS and OS (p<0.001). Age >65 years was associated with poor OS (p =0.008). Using Cox-regression, stage was independent predictor of poor DFS and OS. Age was an independent predictor of poor OS.

• Radiation Oncology Journal
• /
• v.35 no.2
• /
• pp.144-152
• /
• 2017

Purpose: The role of radiotherapy (RT) was largely deserted after the introduction of platinum-based chemotherapy, but still survival rates are disappointingly low. This study focuses on assessing the clinical efficacy of RT in relation to chemotherapy resistance. Materials and Methods: From October 2002 to January 2015, 44 patients were diagnosed with epithelial ovarian cancer (EOC) and treated with palliative RT for persistent or recurrent EOC. All patients received initial treatment with optimal debulking surgery and adjuvant platinum-based chemotherapy. The biologically effective dose (BED) was calculated with ${\alpha}/{\beta}$ set at 10. Ninety-four sites were treated with RT with a median BED of 50.7 Gy (range 28.0 to 79.2 Gy). The primary end-point was the in-field local control (LC) interval, defined as the time interval from the date RT was completed to the date any progressive or newly recurring disease within the RT field was detected on radiographic imaging. Results: The median follow-up duration was 52.3 months (range 7.7 to 179.0 months). The 1-year and 2-year in-field LC rates were 66.0% and 55.0%, respectively. Comparisons of percent change of in-field tumor response showed similar distribution of responses among chemoresistant and chemosensitive tumors. On multivariate analysis of predictive factors for in-field LC analyzed by sites treated, $BED{\geq}50Gy$ (hazard ratio, 0.4; confidence interval, 0.2-0.9; p = 0.025) showed better outcomes. Conclusion: Regardless of resistance to platinum-based chemotherapy, RT can be a feasible treatment modality for patients with persistent of recurrent EOC. The specific role of RT using updated approaches needs to be reassessed.

• Asian Pacific Journal of Cancer Prevention
• /
• v.15 no.10
• /
• pp.4275-4279
• /
• 2014

Background: The aim of this work is to assess the frequency of BRCA1 protein immunohistochemical (IHC) expression in epithelial ovarian cancer (EOC) and to evaluate the association of BRCA1 expression with clinical and pathological characteristics and the overall survival (OS) of patients treated with postoperative platinum-based chemotherapeutic agents. Materials and Methods: This retrospective study was conducted on 35 cases of epithelial ovarian cancer selected from the files of the Pathology Department, Faculty of Medicine, Mansoura University, Egypt. Immunohistochemistry (IHC) was performed for BRCA1 gene protein. BRCA1 expression was compared to patient's age, tumor histology, grade, stage and OS time. Statistical analysis was carried out with the SPSS version 16.0 to assess significant associations. Results: BRCA1 nuclear expression was detected in 40% of EOC, in which a mild increase in the percentage of positive cases was observed with serous histology, stage IV, and grade 3 carcinomas. There was a significant statistical difference in BRCA1 expression with regard to histological subtypes of EOC (p=0.048), but not grade or stage. Mean OS and survival rate were slightly better for BRCA1 expressing group, but there was no statistically significant difference (p=0.528). Conclusions: No association between BRCA1 immunohistochemical expression and tumor grade, stage or overall survival was noted in platinum-treated epithelial ovarian cancer patients.

• Asian Pacific Journal of Cancer Prevention
• /
• v.17 no.3
• /
• pp.1445-1448
• /
• 2016

Purpose: The current study aimed at assessing the association between neutrophil-lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) for the prognosis of the surgical outcome of epithelial ovarian cancer (EOC). Materials and Methods: EOC patient medical records of surgical operations between January, 2005 and December, 2015 were reviewed and their data of clinicopathological complete blood counts (CBCs) and surgical outcomes were collected. To assess their effects on surgical outcomes, PLR and NLR optimal predictive values were determined and then compared with each other. Results: A statistically significant relation was found between surgical outcomes and NLR and PLR (p<0.001 and p<0.001), for which new cutoff points were gained (PLR: 192,3,293; NLR: 3). The sensitivity and specificity were 0.74 and 0.67, respectively for PLR and 0.74 and 0.58, for NLR. Conclusions: NLR and PLR seem to be useful methods for the prediction of surgical outcomes in patients with EOCs. Increased NLR and PLR proved to be beneficial for poor surgical outcomes. Moreover, PLR increase showed further help in the predicting outcome of EOC suboptimal debulking.

• Journal of the Korean Society of Surveying, Geodesy, Photogrammetry and Cartography
• /
• v.23 no.2
• /
• pp.137-145
• /
• 2005

In this paper, we investigate the accuracy of various sensor models developed for linear pushbroom satellite images. We define the accuracy of a sensor model in two aspects: the accuracy of bundle adjustments and the accuracy of estimating exterior orientation parameters. The first accuracy has been analyzed and reported frequently whereas the second accuracy has somewhat been neglected. We argue that the second accuracy is as important as the first one. The second accuracy describes a model's ability to predict satellite orbit and attitude, which has many direct and indirect applications. Analysis was carried out on the traditional collinearity-based sensor models and orbit-based sensor models. Collinearity-based models were originally developed for aerial photos and modified for linear pushbroom-type satellite images. Orbit-based models have been used within satellite communities for satellite control and orbit determination. Models were tested with two Kompsat-1 EOC scenes and GPS-driven control points. Test results showed that orbit-based models produced better estimation of exterior orientation parameters while maintained comparable accuracy on bundle adjustments.

• Korean Journal of Remote Sensing
• /
• v.18 no.6
• /
• pp.337-344
• /
• 2002

In general, in order to obtain position information from satellite images, satellite sensor model which represents the geometric relationship between sensor and targeted area should be established in the first place. However, it is not simple for modelling pushbroom satellite sensor due to the image capturing process. In recent development of new generation imaging sensors, a generic sensor model, which is applicable to all types of sensors such as frame, pushbroom, whiskbroom, and SAR is in great need to the remote sensing and photogrammetry community. In this paper, the RFM as sensor model was implemented with KOMPSAT EOC and SPOT satellite images and analyzed in cases where the number and distribution of ground control points were varied. The test results of RFM were presented and compared with those of Direct Linear Transformation(DLT).

• Science of Emotion and Sensibility
• /
• v.14 no.4
• /
• pp.525-530
• /
• 2011

Emotion is composed of various feelings such as pleasure, sorrow, comfortability, and so on. The complicated process of the measurement has long been recognized as a major hindrance for the studies of emotion. Previously, individuals' emotion has mainly been measured by means of self-report, interview, EEG (electroencephalogram), ECG (electrocardiogram), EOG (electroculography), and body temperature. With thanks to nano/micro technologies, the possibility in the development of emotion-on-a-chip (EOC) has begun to be proposed. EOC will make it possible to analyze one's psychological status by taking a drop of blood. Discovery of emotional biomarkers in body fluids, understanding of the correlation between those biomarkers and the results from brain science are prerequisites to validate the EOC technology. In this paper, paper microfluidics are introduced as a good candidate for the EOC. As paper microfluidics is cost-effective and easy to use it is expected to be a useful device for the emotion measurement. We present the design and fabrication process for the simple paper-based microfluidic device and discuss the possible application in the field of measuring the human emotion.

• Journal of Preventive Medicine and Public Health
• /
• v.49 no.6
• /
• pp.349-366
• /
• 2016

Objectives: We conducted a systematic review and meta-analysis to summarize current evidence regarding the association of parity and duration of breastfeeding with the risk of epithelial ovarian cancer (EOC). Methods: A systematic search of relevant studies published by December 31, 2015 was performed in PubMed and EMBASE. A random-effect model was used to obtain the summary relative risks (RRs) and 95% confidence intervals (CIs). Results: Thirty-two studies had parity categories of 1, 2, and ${\geq}3$. The summary RRs for EOC were 0.72 (95% CI, 0.65 to 0.79), 0.57 (95% CI, 0.49 to 0.65), and 0.46 (95% CI, 0.41 to 0.52), respectively. Small to moderate heterogeneity was observed for one birth (p<0.01; Q = 59.46; $I^2=47.9%$). Fifteen studies had breastfeeding categories of <6 months, 6-12 months, and >13 months. The summary RRs were 0.79 (95% CI, 0.72 to 0.87), 0.72 (95% CI, 0.64 to 0.81), and 0.67 (95% CI, 0.56 to 0.79), respectively. Only small heterogeneity was observed for <6 months of breastfeeding (p = 0.17; Q = 18.79, $I^2=25.5%$). Compared to nulliparous women with no history of breastfeeding, the joint effects of two births and <6 months of breastfeeding resulted in a 0.5-fold reduced risk for EOC. Conclusions: The first birth and breastfeeding for <6 months were associated with significant reductions in EOC risk.